OMRON HEALTHCARE UK LIMITEDActive
Key figures
Ratios
2022/23Balance sheet structure
Dividends
from the accountsDividends paid in the financial year: £273,000.
Filed accounts2019/20–2022/23
| 2019/20 | 2020/21 | 2021/22 | 2022/23 | |
|---|---|---|---|---|
| Turnover | 14,974,204 | 19,475,278 | 14,814,710 | 13,047,582 |
| Profit for the year | 344,714 | 1,184,684 | 194,834 | -906,948 |
| Total assets | 6,063,549 | 10,759,918 | 6,586,111 | 5,781,192 |
| Total liabilities | — | — | — | — |
| Net assets / total equity | 2,837,883 | 3,850,567 | 3,452,401 | 2,272,453 |
| Average number of employees | 14 | 13 | 12 | 10 |
| Average pay (per year) | 54,438 | 56,094 | 54,672 | 93,450 |
| Dividends paid | 300,000 | 172,000 | 593,000 | 273,000 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Principal activity
Accounts 2023The principal activity of the company in the year under review was that of the distribution of healthcare products.
As described in the company's latest filed accounts.
Summary: OMRON HEALTHCARE UK LIMITED
Company
OMRON HEALTHCARE UK LIMITED is a private limited company registered with Companies House under company number 02498080. It was incorporated on 2 May 1990. Its status is active. The registered office is in Milton keynes (MK5). Its nature of business (SIC 2007) is wholesale of pharmaceutical goods (46460).
Accounts
The latest accounts in the database are for 2022/23 (period ending 31 Mar 2023); the company files full accounts. Turnover was £13,047,582. Loss for the year was £906,948. Net assets were £2,272,453, down 34.2% on the previous year. The company had an average of 10 employees. Figures are available for 4 financial years (2019/20–2022/23).
Control and charges
One person with significant control is registered.
Filing deadlines
The next accounts are due by 31 Dec 2027. The next confirmation statement is due by 16 May 2027.